Abstract:Objective To investigate the effects of Exenatide on insulinoma cells-1 (INS-1 cells) in intermittent high glucose, and study the related molecular mechanism of cell proliferation changes. Methods The cells were divided into 5 groups:normal glucose group, which the cells were cultured in the RPMI-1640 complete medium containing 5.5 mmol/L glucose;constant high glucose group, which the cells were cultured in the RPMI-1640 complete medium with 30.0 mmol/L glucose;intermittent high glucose group, which the cells were cultured in rotation per 24-hour in the RPMI-1640 complete medium containing 5.5 mmol/L or 30.0 mmol/L glucose;constant high glucose+Exenatide group, which the cells were cultured in RPMI-1640 complete medium with 30.0 mmol/L glucose and 100.0 nmmol/L Exenatide; intermittent high glucose + Exenatide group, which the cells were cultured in rotation per 24-hour in 5.5 mmol/L or 30.0 mmol/L glucose RPMI-1640 complete medium with 100.0 nmmol/L Exenatide. The cells were cultured at 37 ℃ in 5 % CO2 incubator for 7 days, Cell Counting Kit-8 was used to detect the proliferation activity, and cell cycle progression was detected by propidium iodide staining and flow cytometry. The expression of cyclin D1 and p21 were detected by Western blot. Results The cell proliferation activity of constant high glucose+Exenatide group and intermittent high glucose+Exenatide group was not significantly different as compared with that of normal glucose group, but higher than that of constant high glucose group and intermittent high glucose group (F=3 026, P=0.000). The G0/G1 phase cell proportion in constant high glucose+Exenatide group (49.12%± 3.72%) and intermittent high glucose+Exenatide group(49.73%±4.04%) was not significantly different as compared with that in normal glucose group, but lower than that in constant high glucose group(56.54%± 3.50%) and intermittent high glucose group(65.54%± 3.63%) (F=20.054, P=0.000). The cyclin D1 expression in constant high glucose + Exenatide group (0.41 ± 0.02) and intermittent high glucose + Exenatide group (0.43 ± 0.07) was not significantly different as compared with that in normal glucose group, but significantly higher than that of constant high glucose group (0.31 ± 0.02) and intermittent high glucose group (0.18 ± 0.03 ) (F=29.284, P=0.000). The p21 expression in constant high glucose+Exenatide group (0.21 ± 0.05) and intermittent high glucose+Exenatide group(0.22 ± 0.03) was not significantly different as compared with that in normal glucose group, but significantly lower than that in constant high glucose group(0.40 ± 0.03) and intermittent high glucose group(0.51 ± 0.04)(F=40.296, P=0.000). Conclusion It is demonstrated that in intermittent or constant high glucose, the Exenatide could increase the INS-1 cell cycle progression by up-regulating the expression of cyclin D1 and own regulating the expression of cell cycle inhibitory protein p21.

Glucagon-Like Skin-1’s Effect on Islet β Cells in High Glucose via AMPK/mTOR Pathway

Glucagon-like peptide-1 analog-mediated protection against cholesterol-induced apoptosis via mammalian target of rapamycin activation in pancreatic βTC-6 cells -1mTORβTC-6.

Glucotoxicity and Α Cell Dysfunction: Involvement of the PI3K/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal Αtc1-6 Cells.

Glucagon-Like Peptide-1 Analog-Mediated Protection Against Cholesterol-Induced Apoptosis Via Mammalian Target Of Rapamycin Activation In Pancreatic Beta Tc-6 Cells

Glucagon-like peptide-1 receptor mediates the improvement in glycolipid metabolism disorder via AKT and AMPK signalling pathways in L02 cells with insulin resistance

Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway

Effect of Glucagon-Like Peptide 1 on the Proliferation and Apoptosis of Rat Pancreatic Islet

Impact of glucotoxicity on TC1-6 cell glucagon secretion

Glucagon-like Peptide 1 Protects Microvascular Endothelial Cells by Inactivating the PARP-1/iNOS/NO Pathway.

Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE–/– Mice

Effect of GLP-1 on High Glucose-Induced Human Umbilical Vein Endothelial Cell Apoptosis and Mechanism

Ghrelin Regulates the Proliferation and Apoptosis of High Glucose‐induced Islet Cells Through the PI3K–Akt Signaling Pathway

IGF?1 inhibited the apoptosis of gastric smooth muscle cells induced by high glucose through AMPK?Akt?mTOR pathway

Insulin Regulates Glucagon-Like Peptide-1 Secretion by Pancreatic Alpha Cells.

Pharmacological Effects of EGLP-1, a Novel Analog of Glucagon-Like Peptide-1, on Carbohydrate and Lipid Metabolism

Glucose Metabolism-Related Protein 1 (GMRP1) Regulates Pancreatic Beta Cell Proliferation and Apoptosis Via Activation of Akt Signalling Pathway in Rats and Mice

Adiponectin Reduces Glucotoxicity-Induced Apoptosis of Ins-1 Rat Insulin-Secreting Cells on A Microfluidic Chip

GLP-1 Analog Liraglutide Enhances Proinsulin Processing in Pancreatic Β-Cells Via a PKA-dependent Pathway.

Glucagon-like Peptide 1 Receptor Agonist Ameliorates the Insulin Resistance Function of Islet Β Cells Via the Activation of PDX-1/JAK Signaling Transduction in C57/BL6 Mice with High-Fat Diet-Induced Diabetes

Glucagon like peptide-1 inhibits apoptosis of MIN6 cell lines induced by palmitic acid

Effects of Exenatide on INS-1 cells and cell cycle protein in intermittent high glucose